Table 3.
Mean IMT | Maximum IMT | |||
---|---|---|---|---|
β(SE) | P | β(SE) | P | |
Model 1 | ||||
VMS trajectory | ||||
Consistently low | ------ | ----- | ||
Early onset | .04(.01) | .004 | .05(.01) | .0006 |
Late onset | −.01(.01) | .50 | −.01(.01) | .50 |
Consistently high | .01(.01) | .30 | .02(.01) | .20 |
Model 2 | ||||
VMS trajectory | ||||
Consistently low | ------ | ----- | ||
Early onset | .03(.01) | .03 | .04(.01) | .008 |
Late onset | −.002(.01) | .90 | −.001(.01) | .90 |
Consistently high | −.001(.01) | .90 | .002(.01) | .90 |
Model 1 covariates: site, age, ethnicity, education
Model 2 covariates: Adjusted for site, age, ethnicity, education, body mass index, systolic blood pressure, high density lipoproteins; low density lipoproteins, triglycerides, homeostatic model assessment, smoking status, diabetes, anxiety, use of cardiovascular medications
IMT = intima media thickness; VMS=vasomotor symptoms